Drawing for REINDOSE

USPTO serial 79158523

REINDOSE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SHARPER JR, SAM
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REINDOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthmaABANDONED—
010Drug delivery systems for the deferred, controlled or immediate release of active substances of pharmaceutical preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2017IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Nov 21, 2016IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Jul 4, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 2, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 24, 2015DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 23, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 2, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jul 2, 2015ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 30, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 3, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 5, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2015GPNXNOTIFICATION PROCESSED BY IB—
Apr 15, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 15, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 15, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 28, 2015ALIEASSIGNED TO LIE—
Mar 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 2, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2015RFNTREFUSAL PROCESSED BY IB—
Feb 19, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 12, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 12, 2015RFRRREFUSAL PROCESSED BY MPU—
Feb 11, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 10, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2015DOCKASSIGNED TO EXAMINER—
Jan 13, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 9, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 8, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance